ABCL / AbCellera Biologics Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

AbCellera Biologics Inc.
US ˙ NasdaqGS ˙ CA00288U1066

Deler fremragende 303,160,487 shares
Insideraktier63.773.913 shares
Insider ejerskab21,04 %
Total Insiders19
Insider-stemningsscore

Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.

Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.

Officers sentiment score

Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.

Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.

Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.

Nøgle Insider Metrics

Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.

For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).

Netto antal insidere, der køber (rang)

2 ( )
199 out of 10953

Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).

Procent af float købt af insidere (rangering)

0.125% ( )
245 out of 10834

Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.

Insiderhandelsdiagram

AbCellera Biologics Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.

Insiderliste og lønsomhedsmålinger

Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.

See our leaderboard of most profitable insider traders.

Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Zachary Bogue 10% Owner - [10%] 73.892 73.892
Andrew Booth Chief Financial Officer - [O] 195.600 195.600
DCVC Bio GP, LLC 10% Owner - [10%] 73.892 73.892
DCVC Bio, L.P. 10% Owner - [10%] 73.892 73.892
Ester Falconer Chief Technology Officer - [O] 875.000 875.000
John Hamer Director - [D] 128.862 128.862
Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Hansen Carl L. G. Chief Executive Officer, Director, 10% Owner - [D] [O] [10%] 898.000 898.000
Michael R Hayden Director - [D] 1.441.642 1.441.642
JNK Capital Management, LLC 10% Owner - [10%] 73.892 73.892
Veronique Lecault Chief Operating Officer, Director - [D] [O] 2.123.456 2.123.456
Andrew Lo Director - [D] 86.938 86.938
Montalbano John S. Director - [D] 226.000 226.000
Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Matthew Ocko 10% Owner - [10%] 73.892 73.892
Stephen Quake Director - [D] 1.565.516 1.565.516
Kiersten Stead 10% Owner - [10%] 73.892 73.892
Tryn Stimart Chief Legal Officer - [O] 250 250
Peter Thiel Director - [D] 24.660 24.660
Thermopylae Holdings Ltd. 10% Owner - [10%] 56.134.097 56.134.097
ZNM Capital Management, LLC 10% Owner - [10%] 73.892 73.892

Report errors via our new Insider Auditing Tool

Track Records af insiderkøb - Kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ABCL / AbCellera Biologics Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2026-02-27 Booth Andrew 42.600 3,4200 42.600 3,4200 145.692 56 4.1500 31.098 21,35
2026-02-27 Thermopylae Holdings Ltd. 38.000 3,4400 38.000 3,4400 130.720
2026-02-26 Thermopylae Holdings Ltd. 177.457 3,2700 177.457 3,2700 580.284
2025-11-26 Montalbano John S. 50.000 3,5692 50.000 3,5692 178.460
2025-03-11 Thermopylae Holdings Ltd. 343.631 2,1600 343.631 2,1600 742.243
2025-03-10 Montalbano John S. 25.000 2,3000 25.000 2,3000 57.500
2025-03-06 Montalbano John S. 60.000 2,3428 60.000 2,3428 140.568
2024-08-29 Thermopylae Holdings Ltd. 283.516 2,6100 283.516 2,6100 739.977
2023-11-08 Montalbano John S. 10.000 4,4600 10.000 4,4600 44.600

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

ABCL / AbCellera Biologics Inc. Insider Trades
Track Records af insidersalg - Kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ABCL / AbCellera Biologics Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2021-09-01 HAMER JOHN 137.351 16,9300 137.351 16,9300 2.325.352 252 5.7200 -1.539.704 -66,21
2021-08-31 HAMER JOHN 162.649 16,9500 162.649 16,9500 2.756.901
2021-06-22 Hayden Michael R 100.000 25,5000 100.000 25,5000 2.550.000
2021-06-09 Booth Andrew 1.200.000 25,5000 1.200.000 25,5000 30.600.000
2021-06-09 Falconer Ester 1.000.000 25,5000 1.000.000 25,5000 25.500.000
2021-06-09 Lecault Veronique 1.000.000 25,5000 1.000.000 25,5000 25.500.000
2021-06-09 Thermopylae Holdings Ltd. 5.598.420 24,0300 5.598.420 24,0300 134.530.033
2021-06-09 Hansen Carl L. G. 401.580 25,5000 401.580 25,5000 10.240.290
2021-06-09 Hansen Carl L. G. 5.598.420 24,0300 5.598.420 24,0300 134.530.033
2021-06-09 Stimart Tryn 1.000.000 25,5000 1.000.000 25,5000 25.500.000

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

ABCL / AbCellera Biologics Inc. Insider Trades
Transaktionshistorik

Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.

Fil
Dato
Handle
Dato
Form Insider Ticker Sikkerhedstitel Kode 10b5-1 Direkte Dyrke motion
Pris
Enhed
Pris
Enheder
Ændret
Værdi
Ændret (1K)
Tilbage
Muligheder
Tilbage
Aktier
2026-03-02 2026-02-27 4 Thermopylae Holdings Ltd. ABCL Common Shares P - Purchase D 3,4400 38.000 131 56.134.097
2026-02-27 2026-02-26 4 Thermopylae Holdings Ltd. ABCL Common Shares P - Purchase D 3,2700 177.457 580 56.096.097
2026-02-27 2026-02-27 4 Booth Andrew ABCL Common Shares P - Purchase D 3,4200 42.600 146 195.600
2025-12-19 3 Quake Stephen Family Foundation ABCL Common Shares I 264.300
2025-12-19 3 Quake Stephen ABCL Common Shares D 371.056
2025-12-19 3 Quake Stephen By Trust ABCL Common Shares I 465.080
2025-12-19 2025-12-18 4 Thermopylae Holdings Ltd. ABCL Common Shares G - Gift D -225.000 55.918.640
2025-11-26 2025-11-26 4 Montalbano John S. ABCL Common Shares P - Purchase D 3,5692 50.000 178 221.000
2025-03-11 2025-03-11 4 Thermopylae Holdings Ltd. ABCL Common Shares P - Purchase D 2,1600 343.631 742 56.143.640
2025-03-10 2025-03-10 4 Montalbano John S. ABCL Common Shares P - Purchase D 2,3000 25.000 57 171.000
2025-03-07 2025-03-06 4 Montalbano John S. ABCL Common Shares P - Purchase D 2,3428 60.000 141 146.000
2024-12-05 2024-12-04 4 Thermopylae Holdings Ltd. ABCL Common Shares G - Gift D -286.000 55.800.009
2024-11-26 2024-11-25 4 Hansen Carl L. G. ABCL Common Shares M - Exercise D 2,7000 56.125 152 898.000
2024-09-24 2024-09-20 4 Hansen Carl L. G. ABCL Common Shares M - Exercise D 2,7000 56.125 152 841.875
2024-08-29 2024-08-29 4 Thermopylae Holdings Ltd. ABCL Common Shares P - Purchase D 2,6100 283.516 740 56.086.009
2024-06-24 2024-06-21 4 Lecault Veronique ABCL Common Shares M - Exercise D 0,1880 83.334 16 2.123.456
2024-06-03 2024-05-31 4 Hansen Carl L. G. ABCL Common Shares M - Exercise D 2,7000 56.125 152 785.750
2024-02-27 2024-02-26 4 Hansen Carl L. G. ABCL Common Shares M - Exercise D 2,7000 56.125 152 729.625
2023-12-19 2023-12-19 4 Thermopylae Holdings Ltd. ABCL Common Shares G - Gift D -210.000 55.802.493
2023-11-27 2023-11-23 4 Hansen Carl L. G. ABCL Common Shares M - Exercise D 2,7000 56.125 152 673.500
2023-11-08 2023-11-08 4 Montalbano John S. ABCL Common Shares P - Purchase D 4,4600 10.000 45 86.000
2023-11-08 2023-11-06 4 Montalbano John S. ABCL Common Shares P - Purchase D 4,6400 20.000 93 76.000
2023-09-26 2023-09-22 4 Hayden Michael R ABCL Common Shares P - Purchase I 4,9100 20.000 98 1.323.397
2023-09-14 2023-09-12 4 Lecault Veronique ABCL Common Shares P - Purchase D 5,1900 20.000 104 2.040.122
2023-08-25 2023-08-24 4 Hansen Carl L. G. ABCL Common Shares M - Exercise D 2,7000 56.125 152 617.375
2023-08-09 2023-08-08 4 Hayden Michael R ABCL Common Shares P - Purchase I 5,9000 30.000 177 1.303.397
2023-05-30 2023-05-26 4 Hansen Carl L. G. ABCL Common Shares M - Exercise D 2,7000 56.125 152 561.250
2023-05-26 2023-05-26 4 Booth Andrew ABCL Common Shares P - Purchase D 6,8500 14.500 99 153.000
2023-05-26 2023-05-26 4 Thermopylae Holdings Ltd. ABCL Common Shares P - Purchase D 6,5211 153.000 998 56.012.493
2023-05-09 2023-05-05 4 Lecault Veronique ABCL Common Shares M - Exercise D 0,1900 250.000 48 2.020.122
2023-02-23 2023-02-22 4 Hansen Carl L. G. ABCL Common Shares M - Exercise D 2,7000 56.125 152 505.125
2022-12-22 2022-12-20 4 Booth Andrew ABCL Common shares G - Gift D -50.000 138.500
2022-12-22 2022-12-20 4 Booth Andrew ABCL Common Shares M - Exercise D 0,1900 50.000 10 188.500
2022-12-20 2022-12-16 4 Thermopylae Holdings Ltd. ABCL Common Shares P - Purchase D 10,0967 85.102 859 55.859.493
2022-11-21 2022-11-18 4 Hansen Carl L. G. ABCL Common Shares M - Exercise D 2,7000 56.125 152 449.000
2022-11-09 2022-10-31 4 Thermopylae Holdings Ltd. ABCL Common Shares G - Gift D -70.000 55.774.391
2022-08-22 2022-08-19 4 Thermopylae Holdings Ltd. ABCL Common Shares P - Purchase D 11,4623 200.000 2.292 55.844.391
2022-08-22 2022-08-18 4 Hansen Carl L. G. ABCL Common Shares M - Exercise D 2,7000 56.125 152 392.875
2022-06-15 2022-06-14 4 Thermopylae Holdings Ltd. ABCL Common Shares P - Purchase D 8,0499 9.173 74 55.644.391
2022-06-15 2022-06-13 4 Thermopylae Holdings Ltd. ABCL Common Shares P - Purchase D 8,0318 54.915 441 55.635.218
2022-06-08 2022-06-06 4 Thermopylae Holdings Ltd. ABCL Common Shares P - Purchase D 7,4981 64.545 484 55.580.303
2022-05-19 2022-05-18 4 Hansen Carl L. G. ABCL Share option (right to buy) M - Exercise D 2,70 -56.125 5.800.872
2022-05-19 2022-05-18 4 Hansen Carl L. G. ABCL Common Shares M - Exercise D 2,7000 56.125 152 336.750
2022-05-17 2022-05-16 4 Lecault Veronique ABCL Common Shares P - Purchase D 6,3389 200.000 1.268 1.770.122
2022-05-17 2022-05-13 4 Thermopylae Holdings Ltd. ABCL Common Shares P - Purchase D 7,2551 300.000 2.177 55.515.758
2022-05-16 2022-05-12 4 Thermopylae Holdings Ltd. ABCL Common Shares P - Purchase D 6,4054 1.408.468 9.022 55.215.758
2022-05-16 2022-05-12 4 Booth Andrew ABCL Common Shares P - Purchase D 5,7900 85.000 492 138.500
2022-03-04 2022-03-04 4 Montalbano John S. ABCL Common Shares P - Purchase D 8,5400 10.000 85 56.000
2022-03-03 2022-03-01 4 Montalbano John S. ABCL Common Shares P - Purchase D 9,0500 20.000 181 46.000
2022-03-01 2022-02-28 4 Lecault Veronique ABCL Common Shares P - Purchase D 8,6600 230.789 1.999 1.570.122
2022-02-25 2022-02-22 4 Hansen Carl L. G. ABCL Share option (right to buy) M - Exercise D 2,70 -56.125 5.856.997
2022-02-25 2022-02-22 4 Hansen Carl L. G. ABCL Common Shares M - Exercise D 2,7000 56.125 152 280.625
2022-02-03 2021-12-08 5 Lecault Veronique ABCL Common Shares G - Gift D -250.000 1.339.333
2022-02-03 2021-11-30 5 Lecault Veronique ABCL Common Shares G - Gift D -83.333 1.339.333
2022-02-03 2021-12-07 5 Thermopylae Holdings Ltd. ABCL Common Shares G - Gift D -750.000 53.807.290
2022-02-03 2021-05-24 5 Thermopylae Holdings Ltd. ABCL Common Shares G - Gift D -1.250.000 54.557.290
2022-02-03 2021-12-07 5 Hansen Carl L. G. ABCL Common Shares G - Gift I -750.000 53.807.290
2022-02-03 2021-05-24 5 Hansen Carl L. G. ABCL Common Shares G - Gift I -1.250.000 54.557.290
2022-02-03 2021-05-24 5 Hansen Carl L. G. ABCL Common Shares G - Gift I -223.500 0
2022-02-03 2021-12-10 5 Booth Andrew ABCL Common Shares G - Gift D -500.000 53.500
2021-12-10 2021-12-10 4 Booth Andrew ABCL Share Options (right to buy) M - Exercise D 0,32 -500.000 5.384.820
2021-12-10 2021-12-10 4 Booth Andrew ABCL Common Shares M - Exercise D 0,3200 500.000 160 553.500
2021-12-10 2021-12-03 4/A Lo Andrew ABCL Share Option (right to buy) A - Award D 14,02 91.325 91.325
2021-12-10 2021-12-07 4 Montalbano John S. ABCL Share option (right to buy) A - Award D 14,55 45.532 579.814
2021-12-10 2021-08-27 4 Montalbano John S. ABCL Share option (right to buy) A - Award D 17,58 34.282 534.282
2021-12-10 2021-12-07 4 Hayden Michael R ABCL Share option (right to buy) A - Award D 14,55 45.532 449.814
2021-12-10 2021-08-27 4 Hayden Michael R ABCL Share option (right to buy) A - Award D 17,58 34.282 674.282
2021-12-09 2021-12-07 4 Lecault Veronique ABCL Share Option A - Award D 14,55 406.020 2.930.154
2021-12-09 2021-12-07 4 Hansen Carl L. G. ABCL Share Option (right to buy) A - Award D 14,55 920.312 5.913.122
2021-12-09 2021-12-07 4 Booth Andrew ABCL Share Option (right to buy) A - Award D 14,55 406.020 5.884.820
2021-12-09 2021-12-07 4 Stimart Tryn ABCL Share Option (right to buy) A - Award D 14,55 270.680 2.311.480
2021-12-09 2021-12-08 4 Lecault Veronique ABCL Share Option (right to buy) M - Exercise D 0,19 -250.000 2.524.134
2021-12-09 2021-12-08 4 Lecault Veronique ABCL Common Shares M - Exercise D 0,1900 250.000 48 1.589.333
2021-12-07 2021-12-03 4 Lo Andrew ABCL Share Option (right to buy) P - Purchase D 14,0200 86.938 1.219 86.938
2021-12-03 2021-11-30 4/A Lecault Veronique ABCL Share Option (right to buy) M - Exercise D 0,19 83.333 2.774.134
2021-12-03 2021-11-30 4/A Lecault Veronique ABCL Common Shares M - Exercise D 0,1900 83.333 16 1.422.666
2021-12-02 2021-11-30 4 Lecault Veronique ABCL Share Option (right to buy) M - Exercise D 0,19 -83.333 2.774.134
2021-12-02 2021-11-30 4 Lecault Veronique ABCL Common Shares M - Exercise D 14,9600 83.333 1.247 1.422.666
2021-11-22 2021-11-18 4 Hansen Carl L. G. ABCL Share option (right to buy) M - Exercise D 2,70 -224.500 4.992.810
2021-11-22 2021-11-18 4 Hansen Carl L. G. ABCL Common Shares M - Exercise D 15,0300 224.500 3.374 224.500
2021-11-15 2021-11-11 4 Thermopylae Holdings Ltd. ABCL Common Shares P - Purchase D 14,7611 202.960 2.996 55.807.290
2021-11-15 2021-11-11 4 Booth Andrew By spouse ABCL Common Shares P - Purchase I 14,6100 14.000 205 130.959
2021-11-15 2021-11-11 4 Booth Andrew ABCL Common Shares P - Purchase D 14,7400 53.500 789 53.500
2021-09-15 2021-09-13 4 Hayden Michael R ABCL Share option (right to buy) M - Exercise I 0,32 270.000 270.000
2021-09-15 2021-09-13 4 Hayden Michael R ABCL Common Shares M - Exercise I 17,7300 270.000 4.787 1.273.397
2021-09-03 2021-09-01 4 Falconer Ester ABCL Share option (right to buy) M - Exercise D 0,31 -875.000 875.000
2021-09-03 2021-09-01 4 Falconer Ester ABCL Common Shares M - Exercise D 16,8900 875.000 14.779 875.000
2021-09-02 2021-09-01 4 HAMER JOHN ABCL Common Shares S - Sale D 16,9300 -137.351 -2.325 128.862
2021-09-02 2021-08-31 4 HAMER JOHN ABCL Common Shares S - Sale D 16,9500 -162.649 -2.757 266.213
2021-08-17 2021-08-16 4 Montalbano John S. ABCL Common Shares P - Purchase D 17,2300 6.000 103 26.000
2021-06-22 2021-06-22 4 Hayden Michael R ABCL Common Shares S - Sale I 25,5000 -100.000 -2.550 1.003.397
2021-06-22 2021-06-18 4 HAMER JOHN ABCL Common Shares J - Other I 73.892 73.892
2021-06-22 2021-06-18 4 HAMER JOHN ABCL Common Shares J - Other I -5.000.000 24.105.761
2021-06-22 2021-06-18 4 DCVC Bio, L.P. ABCL Common Shares J - Other I 73.892 73.892
2021-06-22 2021-06-18 4 DCVC Bio, L.P. ABCL Common Shares J - Other I -5.000.000 24.105.761
2021-06-16 2021-06-15 4 Lecault Veronique ABCL Share Option (right to buy) M - Exercise D 0,19 -333.333 666.667
2021-06-16 2021-06-15 4 Lecault Veronique ABCL Common Shares M - Exercise D 0,1900 333.333 63 1.339.333
2021-06-10 2021-06-09 4 Thermopylae Holdings Ltd. ABCL Common Shares S - Sale D 24,0300 -5.598.420 -134.530 55.604.330
2021-06-10 2021-06-09 4 Hansen Carl L. G. ABCL Common Shares S - Sale I 25,5000 -401.580 -10.240 233.500
2021-06-10 2021-06-09 4 Hansen Carl L. G. ABCL Common Shares S - Sale I 24,0300 -5.598.420 -134.530 55.604.330
2021-06-10 2021-06-09 4 Lecault Veronique ABCL Common Shares S - Sale I 25,5000 -1.000.000 -25.500 273.630
2021-06-10 2021-06-09 4 Booth Andrew ABCL Common Shares S - Sale D 25,5000 -1.200.000 -30.600 0
2021-06-10 2021-06-09 4 Falconer Ester ABCL Common Shares S - Sale D 25,5000 -1.000.000 -25.500 0
2021-06-10 2021-06-09 4 Stimart Tryn ABCL Common Shares S - Sale D 25,5000 -1.000.000 -25.500 250
2021-06-09 2021-06-07 4 Booth Andrew ABCL Share Option (right to buy) M - Exercise D 0,32 -600.000 4.950.000
2021-06-09 2021-06-07 4 Booth Andrew ABCL Share Option (right to buy) M - Exercise D 0,19 -600.000 4.950.000
2021-06-09 2021-06-07 4 Booth Andrew ABCL Common Shares M - Exercise D 0,3200 600.000 192 1.200.000
2021-06-09 2021-06-07 4 Booth Andrew ABCL Common Shares M - Exercise D 0,1900 600.000 114 600.000
2021-06-09 2021-06-07 4 Stimart Tryn ABCL Share Option (right to buy) M - Exercise D 2,30 -250.000 600.000
2021-06-09 2021-06-07 4 Stimart Tryn ABCL Share Option (right to buy) M - Exercise D 0,32 -750.000 1.250.000
2021-06-09 2021-06-07 4 Stimart Tryn ABCL Common Shares M - Exercise D 2,3000 250.000 575 1.000.250
2021-06-09 2021-06-07 4 Stimart Tryn ABCL Common Shares M - Exercise D 0,3200 750.000 240 750.250
2021-04-23 2021-03-19 4 Falconer Ester ABCL Share Option (right to buy) M - Exercise D 0,03 -1.000.000 0
2021-04-23 2021-03-19 4 Falconer Ester ABCL Common Shares M - Exercise D 0,0343 1.000.000 34 1.000.000
2020-12-17 2020-12-15 4 DCVC Bio, L.P. ABCL Series A1 Preferred Shares C - Conversion I -2.105.264 0
2020-12-17 2020-12-15 4 DCVC Bio, L.P. ABCL Convertible Note C - Conversion I 17,00 0
2020-12-17 2020-12-15 4 DCVC Bio, L.P. ABCL Series A2 Preferred Shares C - Conversion I -802.371 0
2020-12-17 2020-12-15 4 DCVC Bio, L.P. ABCL Common Shares C - Conversion I 29.411 29.105.761
2020-12-17 2020-12-15 4 DCVC Bio, L.P. ABCL Common Shares C - Conversion I 29.076.350 29.076.350
2020-12-17 2020-12-15 4 THIEL PETER ABCL Convertible Note C - Conversion I 0
2020-12-17 2020-12-15 4 THIEL PETER ABCL Convertible Note C - Conversion I 0
2020-12-17 2020-12-15 4 THIEL PETER ABCL Convertible Note C - Conversion I 0
2020-12-17 2020-12-15 4 THIEL PETER ABCL Series A2 Preferred Shares C - Conversion I -2.924 0
2020-12-17 2020-12-15 4 THIEL PETER ABCL Series A2 Preferred Shares C - Conversion I -40.105 0
2020-12-17 2020-12-15 4 THIEL PETER ABCL Series A2 Preferred Shares C - Conversion I -334.324 0
2020-12-17 2020-12-15 4 THIEL PETER ABCL Series A2 Preferred Shares C - Conversion I -381.126 0
2020-12-17 2020-12-15 4 THIEL PETER ABCL Common Shares C - Conversion I 24.660 24.660
2020-12-17 2020-12-15 4 THIEL PETER ABCL Common Shares C - Conversion I 382.357 382.357
2020-12-17 2020-12-15 4 THIEL PETER ABCL Common Shares C - Conversion I 29.240 29.240
2020-12-17 2020-12-15 4 THIEL PETER ABCL Common Shares C - Conversion I 401.050 401.050
2020-12-17 2020-12-15 4 THIEL PETER ABCL Common Shares C - Conversion I 3.343.240 3.343.240
2020-12-17 2020-12-15 4 THIEL PETER ABCL Common Shares P - Purchase I 20,0000 3.000.000 60.000 10.179.880
2020-12-17 2020-12-15 4 THIEL PETER ABCL Common Shares C - Conversion I 2.477.100 7.179.880
2020-12-17 2020-12-15 4 THIEL PETER ABCL Common Shares C - Conversion I 3.811.260 4.702.780
2020-12-17 2020-12-11 4 THIEL PETER ABCL Convertible Note A - Award I 302.950,0000
2020-12-17 2020-12-11 4 THIEL PETER ABCL Convertible Note A - Award I 4.697.050,0000
2020-12-17 2020-12-11 4 THIEL PETER ABCL Convertible Note A - Award I 30.430.000,0000
2020-12-17 2020-12-15 4 HAMER JOHN ABCL Convertible Note C - Conversion I 17,00 0
2020-12-17 2020-12-15 4 HAMER JOHN ABCL Series A1 Preferred Shares C - Conversion I -2.105.264 0
2020-12-17 2020-12-15 4 HAMER JOHN ABCL Series A2 Preferred Shares C - Conversion I -802.371 0
2020-12-17 2020-12-15 4 HAMER JOHN ABCL Common Shares C - Conversion I 29.411 29.105.761
2020-12-17 2020-12-15 4 HAMER JOHN ABCL Common Shares C - Conversion I 29.076.350 29.076.350
2020-12-17 2020-12-11 4 HAMER JOHN ABCL Convertible Note A - Award I 500.000,0000
2020-12-17 2020-12-15 4 Stimart Tryn By spouse ABCL Common Shares P - Purchase I 20,0000 250 5 250
2020-12-17 2020-12-15 4 Stimart Tryn ABCL Common Shares P - Purchase D 20,0000 250 5 250
2020-12-17 2020-12-10 4 Stimart Tryn ABCL Stock Option (right to buy) A - Award D 20,00 190.800 190.800
2020-12-17 2020-10-29 4 Stimart Tryn ABCL Stock Option (right to buy) A - Award D 2,41 850.000 850.000
2020-12-17 2020-12-15 4 Hayden Michael R ABCL Convertible Note C - Conversion I 17,00 0
2020-12-17 2020-12-15 4 Hayden Michael R By spouse ABCL Common Shares P - Purchase I 20,0000 73.665 1.473 118.245
2020-12-17 2020-12-15 4 Hayden Michael R ABCL Common Shares C - Conversion I 117.647 1.103.397
2020-12-17 2020-12-11 4 Hayden Michael R ABCL Convertible Note A - Award I 2.000.000,0000
2020-12-17 2020-11-18 4 Hayden Michael R ABCL Stock Option (right to buy) A - Award D 2,76 100.000 100.000
2020-12-17 2020-11-06 4 Hayden Michael R ABCL Stock Option (right to buy) M - Exercise I 0,33 -270.000 540.000
2020-12-17 2020-11-06 4 Hayden Michael R ABCL Common Shares M - Exercise I 0,3300 270.000 89 985.750
2020-12-17 2020-12-15 4 Lecault Veronique By spouse ABCL Common Shares P - Purchase I 20,0000 17.000 340 61.580
2020-12-17 2020-12-15 4 Lecault Veronique ABCL Common Shares P - Purchase D 20,0000 6.000 120 1.006.000
2020-12-17 2020-12-10 4 Lecault Veronique ABCL Stock Option (right to buy) A - Award D 20,00 190.800 190.800
2020-12-17 2020-10-29 4 Lecault Veronique ABCL Stock Option (right to buy) A - Award D 2,41 2.000.000 2.000.000
2020-12-17 2020-12-15 4 Montalbano John S. By spouse ABCL Common Shares P - Purchase I 20,0000 5.000 100 5.000
2020-12-17 2020-12-15 4 Montalbano John S. ABCL Common Shares P - Purchase D 20,0000 20.000 400 20.000
2020-12-17 2020-11-18 4 Montalbano John S. ABCL Stock Option (right to buy) A - Award D 2,41 500.000 500.000
2020-12-11 3 Thermopylae Holdings Ltd. ABCL Common Shares D 61.202.750
2020-12-11 3 Lecault Veronique ABCL Common Shares I 7.155.008
2020-12-11 3 Lecault Veronique ABCL Common Shares D 1.000.000
2020-12-11 3 Lecault Veronique By spouse ABCL Common Shares I 44.580
2020-12-11 3 Lecault Veronique ABCL Common Shares I 1.273.630
2020-12-11 3 Booth Andrew By spouse ABCL Common Shares I 116.959
2020-12-11 3 Hayden Michael R By spouse ABCL Common Shares I 44.580
2020-12-11 3 Hayden Michael R ABCL Common Shares I 985.750
2020-12-11 3 Hansen Carl L. G. ABCL Common Shares I 61.202.750
2020-12-11 3 Hansen Carl L. G. ABCL Common Shares I 625.080
2020-12-11 3 THIEL PETER ABCL Common Shares I 891.520
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
Other Listings
DE:8QQ 3,39 €
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista